David Mushatt, MD, MPH&TM
Associate Professor of Clinical Medicine
Chief, Section of Infectious Diseases
Director, Section of Infectious Diseases Fellowship Program
Dr. Mushatt received his medical degree in 1986 from Harvard Medical School. He completed his internal medicine residency training from 1986 - 1989 at the Harvard-affiliated Brigham and Women’s Hospital in Boston, and then did an Infectious Diseases Fellowship at Tulane University School of Medicine from 1989 – 1991. During the second year of his ID fellowship, he also earned an MPH in Tropical Medicine (MPH&TM) at the Tulane School of Public Health and Tropical Medicine.
Dr. Mushatt joined the Tulane ID Section immediately after fellowship, starting out as an Assistant Professor in 1991, and later became Director of the ID Fellowship Program in 2002 and was promoted to Chief of the Section in 2006.
Dr. Mushatt is Principal Investigator of the Louisiana Community AIDS Research Program, the Tulane clinical trials site that was formerly part of the CPCRA and now part of INSIGHT, an NIH-funded international HIV research group that focuses on strategies in HIV treatment at the community level.
Dr. Mushatt enjoys teaching students, residents and fellows and received the Best Subspecialty Attending Award from the Medicine Residency Program in 2008.
Dr. Mushatt’s main research interest is HIV clinical trials, but he also participates in the Mycoses Study Group’s (MSG) protocols. His clinical interests are in HIV medicine, fungal and mycobacterial infections, orthopedic infections and zoonoses. Other interests include human research subjects protections, having served as Vice-Chairman of the Tulane IRB, and the doctor-patient relationship.
Mushatt D, Mihm L, Dreisbach A, Simon E. Antibiotic dosing in slow extended daily dialysis. Clin Infect Dis 2009; 49:433-7.
Mave V, Mushatt D. A case report of a 58-year-old man with laryngeal histoplasmosis mimicking carcinoma and review of the literature. J La State Med Soc 2008; 160:160-3.
Mzayek F, Deng H, Mather FJ, Wasilevich EC, Liu H, Hadi CM, Chansolme DH, Murphy HA, Melek BH, Tenaglia AN, Mushatt DM, Dreisbach AW, Lertora JJL, Krogstad DJ. Randomized dose-ranging controlled trial of AQ-13, a candidate antimalarial, and chloroquine in healthy volunteers. PLoS,Clinical Trials 2007; 2(1):e6. DOI:10.1371/journal.pctr.002000623.
Okoye O, Mushatt D, Schmid J. Persistent anemia in a renal transplant recipient. Clin Infect Dis 2005; 40:1159, 1203-4.
Mushatt DM, Wattanamano P, Alvarado F. Lepromatous leprosy in a renal transplant recipient. Clin Infect Dis 1998; 26:217-218.Hafner R, Bethel J, Power M, Landry B, Banach M, Mole L,
Standiford H, Follansbee S, Kumar P, Raasch R, Cohn D, Mushatt DM, Drusano G. Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. Antimicrob Agents Chemother 1998; 42:631-39.
Witzig RS, Fazal BA, Mera RM, Mushatt DM, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995; 21:77-85.
Mushatt DM, Witzig RS: Successful treatment of Mycobacterium abscessus infections with multidrug regimens containing clarithromycin. Clin Infect Dis 1995; 20:1441-1442.
Mushatt DM, Hyslop NE Jr: Neurologic aspects of North American zoonoses. Infect Dis Clin North Amer 1991; 5:703-731. Mushatt DM: Treatment of Tuberculosis. In: Nichols RL, Hyslop NE and Bartlett JG (Eds): Decision-Making in Surgical Sepsis. Philadelphia, BC Decker, 1991.
1430 Tulane Ave, New Orleans, LA 70112 504-988-5187 email@example.com